RANTES mediates TNF-dependent lamina propria mast cell accumulation and barrier dysfunction in neurogenic cystitis

American Journal of Physiology - Renal Physiology

Volumn 292, Issue 5, 2007, Pages

  Chen, Michael C ^a   Keshavan, Pavitra ^a   Gregory, Greg D ^a,c   Klumpp, David J ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Children's Hospital of Philadelphia ^*  (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Irritable bowel disease; Psoriasis; Transepithelial resistance

Indexed keywords

EOTAXIN; INTERLEUKIN 6; RANTES; STEM CELL FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER DYSFUNCTION; BONE MARROW; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYSTITIS; FEMALE; IN VITRO STUDY; LAMINA PROPRIA; MAST CELL; MOUSE; NEUROGENIC BLADDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PSEUDORABIES HERPETOVIRUS; UROTHELIUM; VIRUS INFECTION;

EID: 34247898865     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00472.2006     Document Type: Article

References (49)

1. Ajuebor MN, Hogaboam CM, Kunkel SL, Proudfoot AE, Wallace JL. The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. J Immunol 166: 552-558, 2001.
2. Alagiri M, Chottiner S, Ratner V, Slade D, Hanno PM. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology 49: 52-57, 1997.
3. Ansari N, Abdulla J, Zayyani N, Brahmi U, Taha S, Abdel Satir A. Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis? J Clin Pathol 59: 1066-1072, 2006.
4. Bamias G, Sugawara K, Pagnini C, Cominelli F. The Th1 immune pathway as a therapeutic target in Crohn's disease. Curr Opin Investig Drugs 4: 1279-1286, 2003.
5. Beqaj SH, Donovan JL, Liu DB, Harrington DA, Alpert SA, Cheng EY. Role of basic fibroblast growth factor in the neuropathic bladder phenotype. J Urol 174: 1699-1703, 2005.
6. Bouchelouche K, Alvarez S, Horn T, Nordling J, Bouchelouche P. Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1- and tumor necrosis factor-α. Urology 67: 214-219, 2006.
7. Boucher W, el-Mansoury M, Pang X, Sant GR, Theoharides TC. Elevated mast cell tryptase in the urine of patients with interstitial cystitis. Br J Urol 76: 94-100, 1995.
8. Buffington CA, Chew DJ, Woodworth BE. Feline interstitial cystitis. J Am Vet Med Assoc 215: 682-687, 1999.
9. Card J, Enquist L. Neurovirulence of pseudorabies virus. Crit Rev Neurobiol 9: 137-162, 1995.
10. Chen MC, Blunt LJ, Pins MR, Klumpp DJ. TNF promotes differential trafficking of bladder mast cells in neurogenic cystitis. J Urol 175: 754-759, 2006.
11. Chen MC, Blunt LW, Pins MR, Klumpp DJ. Tumor necrosis factor promotes differential trafficking of bladder mast cells in neurogenic cystitis. J Urol 175: 754-759, 2006.
12. Chen MC, Mudge CS, Klumpp D. Urothelial lesion formation is mediated by TNFR1 during neurogenic cystitis. Am J Physiol Renal Physiol 291: F741-F749, 2006.
13. Chensue SW, Warmington KS, Allenspach EJ, Lu B, Gerard C, Kunkel SL, Lukacs NW. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J Immunol 163: 165-173, 1999.
14. Daha LK, Riedl CR, Hohlbrugger G, Knoll M, Engelhardt PF, Pfluger H. Comparative assessment of maximal bladder capacity 0.9% NaCl versus 02 M Kcl, for the diagnosis of interstitial cystitis: a prospective controlled study. J Urol 170: 807-809, 2003.
15. De Paulis A, Annunziato F, Di Gioia L, Romagnani S, Carfora M, Beltrame C, Marone G, Romagnani P. Expression of the chemokine receptor CCR3 on human mast cells. Int Arch Allergy Immunol 124: 146-150, 2001.
16. Doggweiler R, Jasmin L, Schmidt RA. Neurogenically mediated cystitis in rats: an animal model. J Urol 160: 1551-1556, 1998.
17. El-Mansoury M, Boucher W, Sant GR, Theoharides TC. Increased urine histamine and methylhistamine in interstitial cystitis. J Urol 152: 350-353, 1994.
18. Fukuoka M, Ogino Y, Sato H, Ohta T, Komoriya K, Nishioka K, Katayama I. RANTES expression in psoriatic skin and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br J Dermatol 138: 63-70, 1998.
19. Furuichi K, Wada T, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, Kobayashi K, Takasawa K, Kida H, Takeda SI, Mukaida N, Matsushima K, Yokoyama H. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases. Am J Nephrol 20: 291-299, 2000.
20. Gay S, Kresina TF, Gay R, Miller EJ, Montes LF. Immunohistochemical demonstration of basement membrane collagen in normal human skin and in psoriasis. J Cutan Pathol 6: 91-95, 1979.
21. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 140: 203-206, 1988.
22. Held P, Hanno P, Wein A, Pauly M, Cahn M. Epidemiology of interstitial cystitis. In: Interstitial Cystitis, edited by PM H, Staskin D, Krane R, and Wein A. London: Springer-Verlag, 1990, p. 29-48.
23. Jasmin L, Janni G, Manz HJ, Rabkin SD. Activation of CNS circuits producing a neurogenic cystitis: evidence for centrally induced peripheral inflammation. J Neurosci 18: 10016-10029, 1998.
24. Jasmin L, Janni G, Ohara PT, Rabkin SD. CNS induced neurogenic cystitis is associated with bladder mast cell degranulation in the rat. J Urol 164: 852-855, 2000.
25. Jones CA, Nyberg L. Epidemiology of interstitial cystitis. Urology 49: 2-9, 1997.
26. Juremalm M, Olsson N, Nilsson G. Selective CCL5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. Biochem Biophys Res Commun 297: 480-485, 2002.
27. Klumpp DJ, Rycyk MT, Chen MC, Thumbikat P, Sengupta S, Schaeffer AJ. Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis. Infect Immun 74: 5106-5113, 2006.
28. Leiby BE, Landis JR, Propert KJ, Tomaszewski JE. Discovery of morphological subgroups that correlate with severity of symptoms in interstitial cystitis: a proposed biopsy classification system. J Urol 177: 142-148, 2007.
29. Lokeshwar VB, Selzer MG, Unwala DJ, Estrella V, Gomez MF, Golshani R, Kester RR, Klumpp DJ, Gousse AE. Uronate peaks and urinary hyaluronic acid levels correlate with interstitial cystitis severity. J Urol 176: 1001-1007, 2006.
30. Marfaing-Koka A, Devergne O, Gorgone G, Portier A, Schall TJ, Galanaud P, Emilie D. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol 154: 1870-1878, 1995.
31. Mudge CS, Klumpp DJ. Induction of the urothelial differentiation program in the absence of stromal cues. J Urol 174: 380-385, 2005.
32. O'Sullivan M, Clayton N, Breslin NP, Harman I, Bountra C, McLaren A, O'Morain CA. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 12: 449-457, 2000.
33. Ochi H, Hirani WM, Yuan Q, Friend DS, Austen KF, Boyce JA. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med 190: 267-280, 1999.
34. Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M. Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol 111: 1185-1199; quiz 1200, 2003.
35. Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 150: 823- 832, 1997.
36. Parsons CL. Argument for the use of the potassium sensitivity test in the diagnosis of interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 16: 428-429, 2005.
37. Parsons CL, Stein PC, Bidair M, Lebow D. Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn 13: 515-520, 1994.
38. Philip J, Willmott S, Irwin P. Interstitial cystitis versus detrusor overactivity: a comparative, randomized, controlled study of cystometry using saline and 0.3 M potassium chloride. J Urol 175: 566 -570, 2006.
39. Ratliff TL, Klutke CG, Hofmeister M, He F, Russell JH, Becich MJ. Role of the immune response in interstitial cystitis. Clin Immunol Immunopathol 74: 209-216, 1995.
40. Romagnani P, De Paulis A, Beltrame C, Annunziato F, Dente V, Maggi E, Romagnani S, Marone G. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol 155: 1195-1204, 1999.
41. Schroder JM, Noso N, Sticherling M, Christophers E. Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammation. J Leukoc Biol 59: 1-5, 1996.
42. Shanahan F. Crohn's disease. Lancet 359: 62-69, 2002.
43. Stellato C, Beck LA, Gorgone GA, Proud D, Schall TJ, Ono SJ, Lichtenstein LM, Schleimer RP. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J Immunol 155: 410-418, 1995.
44. Strack AM, Loewy AD. Pseudorabies virus: a highly specific transneuronal cell body marker in the sympathetic nervous system. J Neurosci 10: 2139-2147, 1990.
45. Tomaszewski JE, Landis JR, Russack V, Williams TM, Wang LP, Hardy C, Brensinger C, Matthews YL, Abele ST, Kusek JW, Nyberg LM. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study. Urology 57: 67-81, 2001.
46. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 38: 1590-1595, 1993.
47. Wu XR, Lin JH, Walz T, Haner M, Yu J, Aebi U, Sun TT. Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. J Biol Chem 269: 13716-13724, 1994.
48. Wu XR, Sun TT. Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein. J Cell Sci 106: 31-43, 1993.
49. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127, 2000.